Laboratory Based Surveillance of HIV-1 Acquired Drug Resistance in Cameroon: Implications for Use of Tenofovir-Lamivudine-Dolutegravir (TLD) as Second- or Third-Line Regimens
Article in Viruses (August 2023)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
High Prevalence of Doravirine Resistance in HIV-1-Infected Patients with Virological Failure to an NNRTI-Based Single-Tablet Regimen
Article in Infection and Drug Resistance (July 2022)
Biobased Products for Viral Diseases
Book chapter (March 2022)